Who are DexCom, Inc.'s main suppliers?

DexCom, Inc. (DXCM) key suppliers include: APPLICATION-SPECIFIC-INTEGRATED-CIRCUITS-SUPPLIE, POLYMERS-SUPPLIERS, SEALS-SUPPLIERS, Abbott Laboratories, Abbott Laboratories and 2 more. View the full supplier network at chainsifter.com/chain/DXCM.

Who are DexCom, Inc.'s major customers?

DexCom, Inc. (DXCM) key customers include: Abbott Laboratories, Abbott Laboratories, Medtronic plc, Medtronic plc, ABBOTT-DIABETES-CARE-INC and 4 more. View the full customer network at chainsifter.com/chain/DXCM.

What sector is DexCom, Inc. in?

DexCom, Inc. (DXCM) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

DXCM Supply Chain: DexCom, Inc. Supplier List & 19 Relationships

7Suppliers

9Customers

3Debt Items

20Related Chains

DexCom, Inc. Suppliers

Ticker	Name	Confidence	Evidence
APPLICATION-SPECIFIC-INTEGRATED-CIRCUITS-SUPPLIE	APPLICATION-SPECIFIC-INTEGRATED-CIRCUITS-SUPPLIE	90%	As of December 31, 2024, those single sources include suppliers of application-specific integrated circuits used in our transmitters
POLYMERS-SUPPLIERS	POLYMERS-SUPPLIERS	90%	As of December 31, 2024, those single sources include suppliers of application-specific integrated circuits used in our transmitters, seals used for the applicator and certain polymers used to synthe…
SEALS-SUPPLIERS	SEALS-SUPPLIERS	90%	As of December 31, 2024, those single sources include suppliers of application-specific integrated circuits used in our transmitters, seals used for the applicator and certain polymers used to synthe…
ABT	Abbott Laboratories	72%	we have not built a sales force. To complement our direct sales efforts, we have entered into distribution arrangements in North America and several international markets that allow distributors to s…
ABT	Abbott Laboratories	72%	Reciprocal relationship from ABT graph: Reciprocal relationship from DXCM graph: we have not built a sales force. To complement our direct sales efforts, we have entered into distribution arrangement…
MDT	Medtronic plc	72%	Reciprocal relationship from MDT graph: Reciprocal relationship from DXCM graph: Reciprocal relationship from MDT graph: Reciprocal relationship from DXCM graph: Reciprocal relationship from MDT grap…
MDT	Medtronic plc	72%	we have not built a sales force. To complement our direct sales efforts, we have entered into distribution arrangements in North America and several international markets that allow distributors to s…

DexCom, Inc. Customers

Ticker	Name	Confidence	Evidence
ABT	Abbott Laboratories	72%	we have not built a sales force. To complement our direct sales efforts, we have entered into distribution arrangements in North America and several international markets that allow distributors to s…
ABT	Abbott Laboratories	72%	Reciprocal relationship from ABT graph: Reciprocal relationship from DXCM graph: we have not built a sales force. To complement our direct sales efforts, we have entered into distribution arrangement…
MDT	Medtronic plc	72%	Reciprocal relationship from MDT graph: Reciprocal relationship from DXCM graph: we have not built a sales force. To complement our direct sales efforts, we have entered into distribution arrangement…
MDT	Medtronic plc	72%	we have not built a sales force. To complement our direct sales efforts, we have entered into distribution arrangements in North America and several international markets that allow distributors to s…
ABBOTT-DIABETES-CARE-INC	ABBOTT-DIABETES-CARE-INC	62%	ollowing table sets forth the locations of our manufacturing facilities: Location Lease Expiration Dates San Diego, California 2028 (1) Mesa, Arizona 2030 (2) Penang, Malaysia 2082 (3) Athenry, Irela…
DIABETES-GROUP	DIABETES-GROUP	62%	th others, for our products, our future revenue may be reduced and our business may be harmed. Developing and managing a direct sales organization is a difficult, expensive and time-consuming process…
SUCH-AG	SUCH-AG	62%	rsonal information, notify as required, or provide timely notice vary by jurisdiction. In the U.S., most state data breach notification laws consider violations to be unfair or deceptive trade practi…
VERILY-IRELAND-LIMITED	VERILY-IRELAND-LIMITED	62%	h our prior generation CGM systems in its technical capabilities and its indications. Since the G6 is classified by the FDA as a Class II device, it is subject to special controls and modifications o…
VERILY-LIFE-SCIENCE-LLC	VERILY-LIFE-SCIENCE-LLC	62%	h our prior generation CGM systems in its technical capabilities and its indications. Since the G6 is classified by the FDA as a Class II device, it is subject to special controls and modifications o…

DexCom, Inc. Debt Obligations

Instrument	Description	Confidence	Evidence
DXCM-DEBT-9190	Xbrl Convertible	90%	xbrl convertible detail from xbrl 2026-03-31.
DXCM-DEBT-9189	Warrants outstanding: 183800000	90%	xbrl warrant detail from xbrl 2018-12-31.
DXCM-DEBT	Debt stack $1.4B	90%	Market cache reports total debt of $1.4B.

DexCom, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for DexCom, Inc..

DexCom, Inc. Ownership

Holder	Name	Confidence	Evidence
DXCM-OWNER-BLACKROCK-INC	Blackrock Inc.	90%	13F overlay lists Blackrock Inc. as top holder; 10 tracked holders.

DexCom, Inc. Extended Supply Chain Network

Ticker	Name	Chain Index	Hops
IVA	Inventiva S.A.	100.00	2
NBP	NovaBridge Biosciences	100.00	2
EXAS	Exact Sciences Corp	100.00	2
ITGR	Integer Holdings Corporation	100.00	2
ISRG	Intuitive Surgical, Inc.	100.00	2
IINN	Inspira Technologies Oxy B.H.N. Ltd.	100.00	2
GCTK	GlucoTrack, Inc.	100.00	2
AORT	Artivion, Inc.	100.00	2
GWW	W.W. Grainger, Inc.	100.00	2
GIFOF	Grifols, S.A.	100.00	2
GRAL	GRAIL, Inc.	100.00	2
GIFLF	Grifols, S.A.	100.00	2
VTAK	Catheter Precision, Inc.	100.00	2
PSNL	Personalis, Inc.	100.00	2
GRFS	Grifols, S.A.	100.00	2
FLGT	Fulgent Genetics, Inc.	100.00	2
SVA	Sinovac Biotech Ltd.	100.00	2
GIKLY	Grifols, S.A.	100.00	2
ALVO	Alvotech	100.00	2
SSII	SS Innovations International, Inc.	100.00	2

DexCom, Inc. Supply Chain